Format

Send to

Choose Destination
CNS Neurosci Ther. 2012 Mar;18(3):238-42. doi: 10.1111/j.1755-5949.2011.00261.x. Epub 2011 Aug 1.

The effect of pharmacotherapy on suicide rates in bipolar patients.

Author information

1
Department of Clinical and Theoretical Mental Health, Semmelweis University, Budapest, Hungary. rihmerz@kut.sote.hu

Abstract

Suicide is a complex and multicausal human behavior and also a great challenge for psychiatry. We review the evidence available concerning pharmacological prevention of suicide in bipolar disorder patients. Several clinical trials provide evidence that effective acute and long-term treatment of bipolar depression provides a strong protection against suicide, suicide attempts, and probably against other complications of this disorder. Current major mood disorder is the most important risk factor of suicide, and bipolar II patients carry the highest risk. In bipolar patients suicidal behavior is most likely to occur during pure or mixed depressive episodes. Since bipolar disorder is a highly recurrent illness, adequate long-term pharmacotherapy is needed to prevent suicidal behavior.

PMID:
22070662
PMCID:
PMC6493529
DOI:
10.1111/j.1755-5949.2011.00261.x
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center